Cannara to sell five vape cartridge products in Quebec

Mr. Zohar Krivorot reports CANNARA SECURES 5 KEY LISTINGS IN QUEBEC S NEW VAPE CARTRIDGE CATEGORY INCLUDING TO BE RELEASED LIVE ROSIN VAPES Cannara Biotech Inc. has received preliminary acceptance by the Societe Quebecoise du Cannabis (SQDC) of five vape cartridge products to be distributed across all Quebec retail stores in November, 2025 (Q1 FY2026), in addition to being sold on-line via SQDC's e-commerce website. "We are incredibly proud to announce our preliminary approval of five live resin and live rosin vape cartridges to be distributed across Quebec's 107 retail stores. These five SKUs represent 20 per cent of the 25 vape cartridge SKUs the SQDC plans to distribute in-store by calendar year-end," said Zohar Krivorot, president and chief executive officer of Cannara Biotech. "I commend our R&D and commercial teams for their work in creating premium vape formulations that align with both Quebec's specific category regulations and our consumer sensory evaluations." "We are excited to enter Quebec's vape cartridge category launch with our most popular strains in live resin format. Our vertical processes and strong R&D have enabled the creation of vape formulations with no additives, an expertise we developed in becoming Canada's No. 1 premium live resin vape cartridge provider over the last 12 months," said Nicholas Sosiak, chief financial officer of Cannara Biotech. "We are eager to continue our success as Canada's leading premium live resin vape brand and look forward to offering the same premium-quality vape cartridge experience to customers in our home province of Quebec, the last major province to allow vape cartridges." Quebec vape market opportunity The SQDC reported $741.5-million in revenue for the Quebec market in 2024 and a recent survey conducted by the Institut de la statistique du Quebec found that 25 per cent of Quebec consumers vaped in the past year, and 28 per cent of those did so at least weekly. With the vape segment representing approximately 15 per cent of total sales in Alberta, Ontario and British Columbia, Quebec's forthcoming cartridge launch may be one of the largest untapped growth levers in Canada's legal cannabis market. Live rosin vape cartridge launch Cannara is also proud to announce its first entry into the live rosin vape cartridge category. These live rosin vapes represent the highest-quality flower input -- grown, flash-frozen and extracted entirely in house at the company's Valleyfield and Farnham facilities in Quebec. "This launch of live rosin vapes represents the culmination of months of research and development around genetic selection, process refinement and hardware," said Nicholas Sosiak, chief financial officer of Cannara Biotech. "We are excited to bring solventless vapes to our home market of Quebec for the province's vape cartridge category launch and see opportunity for further provincial rollouts in the future." About Cannara Biotech Inc. Cannara Biotech is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Quebec spanning over 1.65 million square feet, providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. We seek Safe Harbor.